Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Spirit Possession
Venus
Different tracks for pathology informatics fellowship training: Experiences of and input from trainees in a large multisite fellowship program.
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Systemic therapy for advanced or recurrent endometrial carcinoma.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Systemic therapy for advanced or recurrent endometrial carcinoma.
Systemic therapy for advanced or recurrent endometrial carcinoma. Curr Oncol Rep. 1999 Sep; 1(1):47-53.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma
Disease-Free Survival
Endometrial Neoplasms
Female
Humans
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Severity of Illness Index
Survival Analysis
authors with profiles
Gini Fleming